Eisai sepsis drug fails in phase III

January 26, 2011
Research and Development, Sales and Marketing Eisai, eritoran, perampanel, sepsis

A new treatment for severe sepsis could be abandoned entirely after phase III results fell short. Eisai’s eritoran did not …

NHS competition will prevent postcode lottery, says Lansley

January 25, 2011
NHS, NHS reforms, postcode prescribing

The government has pledged that value-based competition in the NHS will create “the very opposite of the postcode lottery”, following …

Amgen HQ

Amgen signs $1 billion cancer biotech deal

January 25, 2011
Research and Development Amgen, BioVex, OncoVEXGM-CSF, cancer vaccine

Amgen is set to pay $1 billion for US biotech firm BioVex, in the process gaining access to its novel …

David Jukes promoted to president of Univar Europe

January 25, 2011
Manufacturing and Production David Jukes, John van Osch, manufacturing and production, univar

Chemical distributor Univar has promoted David Jukes to president of its European operations. He replaces John van Osch who is …

Genzyme plans new Belgium facility

January 25, 2011
Manufacturing and Production Belgium, Genzyme, Lumizyme, Myozyme, Pompe disease, Sanofi-Aventis, alglucosidase alfa

US rare disease drug specialist Genzyme, the subject of a hostile takeover offer from France’s Sanofi-Aventis, says that it will …

Bio and clinical plants feature in 2011 FOYA honours

January 25, 2011
Manufacturing and Production MedImmune, Merck & Co, Novartis, Pfizer, Roche, Shire HGT, pharma manufacturing

Three US and three European manufacturing plants have been shortlisted for the annual Facility of the Year awards, with the …

GlaxoSmitKline's headquarters

GSK skin cancer drugs moves into phase III

January 25, 2011
Research and Development BRAF V600 mutation, Cancer, Duchenne Muscular Dystrophy, GSK, GSK1120212, GSK2118436, GSK968, GlaxoSmithKline, melanoma, skin cancer

GlaxoSmithKline has begun late-stage trials of two new drugs for advanced or metastatic melanoma patients. GSK2118436 and GSK1120212 are being …

SHL GM Frank Isaksson to speak at the 2011 Injectable Drug Delivery Conference

January 25, 2011
Manufacturing and Production, Medical Communications auto injector, autoinjector, frank isaksson, injectable drug delivery

With a steadily increasing number of biologics coming to market, the demand for auto injectors and similar devices continues to …

Axon makes US appointment

January 24, 2011
Medical Communications AXON Communications, Mark Khan, appointment, medical communications

Richmond, UK-based comms agency Axon Communications has expanded its stateside operations, appointing Mark Khan as VP of client services and …

Blog footer

Digital Pharma: Pfizer UK’s online surgery (case study)

January 24, 2011
Medical Communications Digital Pharma blog, Facebook advertising, Google Adwords, ManMOT, PR, Pfizer, Twitter, blogs, male health

Pfizer UK’s online male health clinic Man MOT was launched last summer to offer men confidential advice and information about …

Novartis MS drug steals march over Merck rival

January 24, 2011
Sales and Marketing Cladribine, MS, Merck KGaA, Novartis, fingolimod, gilenya, multiple sclerosis

Novartis’ oral multiple sclerosis Gilenya could be on the European market in just three months after winning the backing of …

Novartis offers $470m to boost personalised cancer treatment

January 24, 2011
Research and Development, Sales and Marketing Cancer, Genoptix, Novartis, cancer diagnostics, personalised medicine

Novartis has offered $470 million for a California-based laboratory whose diagnostic services it hopes will enhance personalised treatment. Genoptix specialises …

Contract research news in brief

January 24, 2011
Research and Development AMRI, Applied Clinical Intelligence, Cenix Bioscience, Clinipace Worldwide, ICON, PPD, Pacific Biomarkers, monoclonal antibody

PPD sets up a monoclonal antibody JV in Singapore, plus updates from Icon plc, Cenix Bioscience, Clinipace Worldwide, Pacific Biomarkers, …

OgilvyHealthPR appoints Wendy Gerber and Tania Kouprach-Rolandi

January 24, 2011
Medical Communications OgilvyHealthPR, Tania Kouprach-Rolandi, Wendy Gerber, appointment, medical communications

OgilvyHealthPR has strengthened its London team with the appointments of Wendy Gerber and Tania Kouprach-Rolandi, who will focus on HIV, …

scope_medical_sidrah

Ian Dickety and Sidrah Qureshi join ScopeMedical

January 21, 2011
Medical Communications Ian Dickety, ScopeMedical, Sidrah Qureshi, appointments, medical communications

Kent-based med comms agency ScopeMedical has made two new appointments to its team.Starting at the agency are junior digital developer …

ABPI Code of Practice

Boehringer’s Pradaxa advertising breaches Code

January 21, 2011
Medical Communications ABPI, Bayer Schering Pharma, Boehringer Ingelheim, Code of Practice, PMCPA, Sanofi-Aventis

Boehringer Ingelheim has fallen foul of the ABPI Code of Practice on five counts in a row over an advertisement …

Amgen plant will boost Boehringer Ingelheim’s US presence

January 21, 2011
Manufacturing and Production Abgenix, Amgen, Boehringer Ingelheim, Vectibix, panitumumab, pharma manufacturing

Germany’s Boehringer Ingelheim has agreed to buy a development and manufacturing facility in Fremont, California, from leading biotechnology firm Amgen. …

ABPI

ABPI warns of postcode prescribing

January 21, 2011
Sales and Marketing ABPI, Cancer Drugs Fund, NICE, cancer drug prescribing, postcode prescribing

The ABPI has said the government’s forthcoming Cancer Drugs Fund could increase the problems of postcode prescribing. The UK industry …

Double Helix expands market research division

January 21, 2011
Medical Communications Arijit Ray, Aude Mircovich, Double Helix, Munna Vio, appointment, medical communications

Double Helix has appointed Munna Vio, Arijit Ray and Aude Mircovich (pictured) to its London-based global market research team. Munna …

Pharma manufacturing news in brief

January 21, 2011
Manufacturing and Production Cambrex, Faron Pharmaceuticals, McNeil Consumer Healthcare, NextPharma Technologies, Rentschler Biotechnologie, Sandoz, ShangPharma, Sun European Partners, Teva Pharmaceuticals USA, Unilife Corp

Another J&J recall in the US, plus a round-up of product recalls, acquisitions, facility updates and new contracts in the …

The Gateway to Local Adoption Series

Latest content